Latest Regulatory Breach News

Lucapa Diamond Company Limited’s shares remain suspended following the appointment of voluntary administrators, highlighting severe financial distress and regulatory breaches.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.